Faculty

Bernard HAMELIN, MD
ISMO EU Medical Director
Bernard is European Medical Director of AstraZeneca, Regional office in Brussels, Belgium.
Bernard obtained his Medical degree at the University of Paris, School of Medicine in 1983 and
received his Master in Science degree in Pharmacology and Cellular Biology at the University of Paris in
1987.
Later in 1993, he obtained his eMBAfrom the "Institut Administration des Entreprises" at the University of
Paris.
Bernard practiced at the Hospital of Marseille in Oncology and Radiotherapy and in the Hospital of Paris
in the departments of Hepatogastroenterology, ICU, Kidney Transplantation, Virology and Haematology.
His residency and fellowship was performed in the department of hepatogastro-enterology.
He joined Astra France in 1991 as Clinical Research Physician, Medical Responsible for GI and moved to
Astra Hässle in Mölndal, Sweden in 1994 as Project Team Leader of the mosapride project team.
In 1997, Bernard moved to Astra Merck Pharmaceuticals, PA, USAas Clinical Research Physician and
was the Medical responsible for Nexium (phase II/III) and supported the pre-launch marketing activities for
phase IIIb/IV. In 1999 he was promoted Global Director GI Therapeutical Area and he returned to
AstraZeneca France in 2001 where he was appointed Medical Director.
In 2005, Bernard joined AstraZeneca ISMO, as EU Medical Director and is responsible for the Medical
Affairs, Clinical Research and Medical Information.
____________________________________________________________________________
Desmond JULIAN
Professor Desmond Julian undertook his undergraduate medical education in Cambridge and London,
and trained in cardiology at the National Heart Hospital, London, Harvard Medical School, and Edinburgh.
In 1961 he was the first to put forward the concept of the coronary care unit in an article in the Lancet. In
1962, he went to Sydney, Australia to set up one of the first coronary units. He was Cardiologist in the
Royal Infirmary Edinburgh from 1964 to 1975 and Professor of Cardiology in the University of
Newcastle-upon-Tyne from 1975 to 1986, and subsequently Medical Director of the British Heart
Foundation from 1986 to 1993.
He was President of the British Cardiac Society from 1985-87. He was awarded the Gold Medal of the
European Society of Cardiology in 1998. He received the Mackenzle Medal of the British Cardiac Society
in 2003 and the International Service Award of the American College of Cardiology in 2005. He was
awarded Honorary MDs from the Universities of Gothenburg and Edinburgh.
He was Editor of the European Heart Journal from its inception in 1979 to 1988. He is the author or
editor of some 20 books on cardiological topics. He has been involved in the design, monitoring and
analysis of many of the major clinical trials in cardiology , including ISIS trials, CONSENSUS and 4S.